-
Loading metrics
Open Access
Peer-reviewed
Research Article
Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder
-
Brian M. Balog,
Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Writing – original draft, Writing – review & editing
Affiliations Department of Biomedical Engineering, Lerner Research Institute, the Cleveland Clinic, Cleveland, Ohio, United States of America, Advanced Platform Technology Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, United States of America, Department of Biology, University of Akron, Akron, Ohio, United States of America
⨯ -
Abhilasha Tangada,
Roles Formal analysis, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing
Affiliations Department of Biomedical Engineering, Lerner Research Institute, the Cleveland Clinic, Cleveland, Ohio, United States of America, Advanced Platform Technology Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, United States of America
⨯ -
Pooja Sheth,
Roles Data curation, Formal analysis
Affiliation Department of Biomedical Engineering, Lerner Research Institute, the Cleveland Clinic, Cleveland, Ohio, United States of America
⨯ -
Qi-Xiang Song,
Roles Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing
Affiliations Department of Biomedical Engineering, Lerner Research Institute, the Cleveland Clinic, Cleveland, Ohio, United States of America, Advanced Platform Technology Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, United States of America, Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, People’s Republic of China
⨯ -
Bruna M. Couri,
Roles Methodology, Project administration, Writing – original draft, Writing – review & editing
Affiliations Department of Biomedical Engineering, Lerner Research Institute, the Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Obstetrics and Gynecology, the Cleveland Clinic, Cleveland, Ohio, United States of America
⨯ -
Leah L. Porras,
Roles Project administration, Resources, Writing – review & editing
Affiliation Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯ -
Gary G. Deng,
Roles Project administration, Resources, Writing – review & editing
Affiliation Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯ -
Margot S. Damaser
Roles Formal analysis, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: damasem@ccf.org
Affiliations Department of Biomedical Engineering, Lerner Research Institute, the Cleveland Clinic, Cleveland, Ohio, United States of America, Advanced Platform Technology Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, United States of America, Glickman Urological and Kidney Institute, the Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder
- Brian M. Balog,
- Abhilasha Tangada,
- Pooja Sheth,
- Qi-Xiang Song,
- Bruna M. Couri,
- Leah L. Porras,
- Gary G. Deng,
- Margot S. Damaser
- Published: August 28, 2019
- https://doi.org/10.1371/journal.pone.0220788